HIMS Stock Chart & Fundamental Analysis

Interactive Chart

About HIMS HERS HEALTH INC CLASS A

Name

HIMS HERS HEALTH INC CLASS A

CEO

Andrew Dudum

Website

www.hims.com

Industry

Healthcare

Year Founded

2017

Employees

2,442

Hims & Hers Health, Inc. (NYSE: HIMS) provides consumer-focused healthcare products and services across prescription and nonprescription categories, operating in healthcare with an emphasis on medical products, related services, and digital access. The company generated $2.3 billion in FY2025 revenue.

Analyst Ratings

Consensus Recommendation

Buy1

Hold2

Sell4

Fundamentals & Financials

Revenue (TTM)

$2.3B

Net Income (TTM)

-$13.2M

EPS (TTM)

-$0.05

ROA (TTM)

-0.58%

Current Ratio

1.69

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$608,104K	$617,818K	$598,976K
Cost of Sales	$307,820K	$173,383K	$156,918K
Gross Profit	$300,284K	$444,435K	$442,058K
Operating Income	-$16,469K	$9,186K	$11,807K
Net Income	-$92,115K	$20,601K	$15,774K
EPS	-$0.4	$0.09	$0.07

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

HIMS HERS HEALTH INC CLASS A's Technical Indicators Summary

HIMS shows a neutral profile with mixed signals: momentum readings and several short-term averages point lower while a mid‑term moving average sits below price, creating offsetting pressure. RSI is subdued and the CCI and momentum indicators are bearish, yet stochastic and Williams percentR read as deeply oversold. Trend strength is limited with ADX in the high teens and volatility is elevated with an ATR above 10 percent, while OBV remains negative and the classic pivot lies well above the current price. Technical takeaway: Neutral — oversold indicators conflict with moving-average resistance and weak trend strength.

Buy

1 signal

Neutral

2 signals

Sell

4 signals

Overall: Neutral29% Neutral signals

Indicator	Value	Signal	Explanation
RSI (14)	36.99	Neutral	RSI (36.99) is neutral.
Stochastic %K (14, 3, 3)	9.32	Buy	Stochastic (9.32) < 20, indicating oversold.
CCI (20)	-185.51	Sell	CCI (-185.51) < -100, indicating strong downward momentum.
WPR (14)	-98.50	Buy	Williams %R (-98.50) < -80, indicating oversold.
Momentum (10)	-6.29	Sell	Momentum (-6.29) is negative.
MFI	39.34	Neutral	MFI (39.34) is neutral.
MACD Level (12, 26)	0.00	Neutral	Potential bearish reversal: MACD (0.00) crossed below signal but is still positive.
Bollinger Bands	$29.67 - $39.12	Buy	Price ($28.09) is below the lower band ($29.67).
ATR (14)	$2.85 (10.13%)	Sell	High Volatility (10.13%) suggests increased risk.
ADX (14)	17.68	Neutral	Weak or consolidating trend (ADX < 25). ADX(17.68), +DI(18.33), -DI(23.49)
OBV	-287,160,739	Sell	Bearish volume pressure: OBV is below its 20-day SMA. OBV(-287,160,739), 20D-SMA-OBV(-267,828,369)
Classic Pivot Point	$33.13	Sell	Price ($28.09) has broken below support S1 ($30.42) — bearish momentum confirmed.
Fibonacci Pivot Point	$33.13	Sell	Price ($28.09) has broken below support S1 ($31.21) — bearish momentum confirmed.
Simple Moving Averages	$26.98 - $34.39(5 indicators)	Sell	SMA group: 4/5 bearish, 1 bullish, 0 neutral. Price below key SMA averages.
Exponential Moving Averages	$29.96 - $34.32(5 indicators)	Sell	EMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The session closed with HIMS still feeling the impact of a large -14.20% gap down from yesterday. The day finished with robust liquidity in HIMS, as shares traded at 1.95× average turnover. Analyst CCORF keeps a Buy rating on HIMS with a $40 target, signaling ongoing upside.

Trading Volume

Above 10d avg 14.4M

28M

vs S&P 500 Today

Strong Underperformance

-14.11%

52-Week Position

Lower range

25.3%

Updated: July 24, 2026 at 20:36 UTC